Your browser doesn't support javascript.
loading
Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.
Haddach, Mustapha; Pierre, Fabrice; Regan, Collin F; Borsan, Cosmin; Michaux, Jerome; Stefan, Eric; Kerdoncuff, Pauline; Schwaebe, Michael K; Chua, Peter C; Siddiqui-Jain, Adam; Macalino, Diwata; Drygin, Denis; O'Brien, Sean E; Rice, William G; Ryckman, David M.
Afiliação
  • Haddach M; Cylene Pharmaceuticals Inc., 5820 Nancy Ridge Drive, Suite 200, San Diego, CA 92121, USA. mhaddach@cylenepharma.com
Bioorg Med Chem Lett ; 22(1): 45-8, 2012 Jan 01.
Article em En | MEDLINE | ID: mdl-22169261
ABSTRACT
Protein kinase CK2 is a potential drug target for many diseases including cancer and inflammation disorders. The crystal structure of clinical candidate CX-4945 1 with CK2 revealed an indirect interaction with the protein through hydrogen bonding between the NH of the 3-chlorophenyl amine and a water molecule. Herein, we investigate the relevance of this hydrogen bond by preparing several novel tricyclic derivatives lacking a NH moiety at the same position. This SAR study allowed the discovery of highly potent CK2 inhibitors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Caseína Quinase II / Antineoplásicos Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Caseína Quinase II / Antineoplásicos Idioma: En Ano de publicação: 2012 Tipo de documento: Article